These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LIPID METABOLISM AND THE LAYING HEN. 3. PLASMA LIPOPROTEIN LIPASE IN RELATION TO THE ONSET OF LAYING. HEALD PJ; FURNIVAL BM; ROOKLEDGE KA Biochim Biophys Acta; 1965 Feb; 98():66-72. PubMed ID: 14290840 [No Abstract] [Full Text] [Related]
3. THE EFFECT OF HEPARIN PRETREATMENT ON DEVELOPMENT AND CLEARING OF ALIMENTARY LIPEMIA. Barboriak JJ; Kory RC; Chamilton LH Am J Clin Nutr; 1965 May; 16():412-6. PubMed ID: 14286798 [No Abstract] [Full Text] [Related]
4. [STUDIES ON THE POST HEPARINIC LIPOPRPTEIN LIPASE ACTIVITY IN 6 CASES OF ESSENTIAL HYPERLIPEMIA]. SANDHOFER F; SAILER S; HERBST M; BRAUNSTEINER H Dtsch Med Wochenschr; 1965 Apr; 90():755-9. PubMed ID: 14282977 [No Abstract] [Full Text] [Related]
5. EFFECT OF HEPARIN ON DISAPPEARANCE OF THE CHOLESTEROL MOIETY OF AN INJECTED CHOLESTEROL-C14-LABELED, VERY LOW-DENSITY CHYLE LIPOPROTEIN FRACTION FROM THE CIRCULATION OF THE RAT. LOSSOW WJ; NAIDOO SS; CHAIKOFF IL J Lipid Res; 1963 Oct; 4():419-23. PubMed ID: 14168185 [No Abstract] [Full Text] [Related]
6. STUDIES OF THE INFLUENCE OF DIET ON CLEARING-FACTOR LIPASE (CFL) AND BLOOD LIPID LEVELS OF A PATIENT WITH HYPERLIPIDEMIA. MACNAB M; MACMILLAN RL; MONKHOUSE FC Can Med Assoc J; 1965 Jan; 92(5):217-20. PubMed ID: 14246294 [TBL] [Abstract][Full Text] [Related]
7. AN INVESTIGATION OF ROUTES OF ADMINISTRATION OF HEPARIN OTHER THAN INJECTION. WINDSOR E; FREEMAN L Am J Med; 1964 Sep; 37():408-16. PubMed ID: 14209287 [No Abstract] [Full Text] [Related]
8. DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA. BOBERG J; CARLSON LA Clin Chim Acta; 1964 Nov; 10():420-7. PubMed ID: 14230938 [No Abstract] [Full Text] [Related]
9. Observations on heparin-induced clearing activity in ischaemic heart disease and the effect of prolonged heparin therapy. NESTEL PJ Australas Ann Med; 1961 Feb; 10():29-32. PubMed ID: 13728417 [No Abstract] [Full Text] [Related]
10. LIPOLYTIC ACTIVITY IN THE BLOOD AFTER LIPASE INGESTION. TIDWELL HC; MCPHERSON JC; MOORE WT; POPE JL; FREEMAN A Proc Soc Exp Biol Med; 1964 Jul; 116():720-3. PubMed ID: 14194643 [No Abstract] [Full Text] [Related]
11. SERUM REQUIREMENT FOR RELEASE OF HEPARIN-INDUCED LIPASE FROM PERFUSED RAT HEART. CRASS MF; MENG HC Am J Physiol; 1964 Mar; 206():610-4. PubMed ID: 14162310 [No Abstract] [Full Text] [Related]
12. SUBLINGUAL HEPARIN; THE INABILITY TO DETECT LIPID-CLEARING OR ANTICOAGULANT EFFECTS OF HIGH DOSES. SPUDIS EV; HUTAFF LW; MILLER HS; LOFLAND H Neurology; 1965 May; 15():486-90. PubMed ID: 14288641 [No Abstract] [Full Text] [Related]
13. [LIPID RESEARCH IN DIABETES]. BISERTE G; SEZILLE G; BERTRAND M; JAILLARD J Ann Biol Clin (Paris); 1964; 22():861-97. PubMed ID: 14189619 [No Abstract] [Full Text] [Related]
14. Heparin lipemia clearing reaction and fat transport in man. Summary of available knowledge. Engelberg H Am J Clin Nutr; 1960; 8():21-33. PubMed ID: 13820325 [No Abstract] [Full Text] [Related]
15. POST-HEPARIN LIPOLYTIC ACTIVITY FOLLOWING INTRAVENOUS HEPARIN-S35. PORTE D; WILLIAMS RH Proc Soc Exp Biol Med; 1965 Mar; 118():639-43. PubMed ID: 14264516 [No Abstract] [Full Text] [Related]
16. INHIBITION OF PANCREATIC LIPASE BY CHLORTETRACYCLINE. THE EFFECT OF PANCREATIC LIPASE ON LIPID DIGESTION AND ABSORPTION. KRONDL A; VAVRINKOVA H; MICHALEC C Acta Gastroenterol Belg; 1964 Nov; 27():597-606. PubMed ID: 14266815 [No Abstract] [Full Text] [Related]
17. LIPOIDS IN THE GENESIS OF ATHEROSCLEROSIS. WATSON JH South Med J; 1964 May; 57():507-8. PubMed ID: 14143423 [No Abstract] [Full Text] [Related]
19. HEPARIN AND THE REMOVAL OF TRIGLYCERIDE FROM THE BLOOD STREAM. ENGELBERG H Am J Cardiol; 1964 Jul; 14():8-17. PubMed ID: 14176898 [No Abstract] [Full Text] [Related]
20. [Heparin, lipoprotein lipase and plasma lipids]. Hollmann M Dtsch Med J; 1968 Apr; 19(8):270-8. PubMed ID: 4891142 [No Abstract] [Full Text] [Related] [Next] [New Search]